What does CorMedix Inc. do?
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream…
What is CorMedix Inc.'s P/E and P/B ratio?
CorMedix Inc. has a P/E ratio of 4.0 and a P/B ratio of 1.37.
What is CorMedix Inc.'s debt-to-equity ratio?
CorMedix Inc. has a debt-to-equity ratio of 0.32.
How much does CorMedix Inc. owe compared with what it owns?
CorMedix Inc. owes $0.49 for every $1 it owns (balance sheet Jun 2026), which is low.
What is CorMedix Inc.'s Positivity rank?
CorMedix Inc. is ranked #2,032 of 6,774 companies globally and #552 of 4,000 in United States on PositoAI, with a Positivity Score of 21,985.
Does CorMedix Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
CorMedix Inc. has no active red flags. It has 1 yellow flag (PosiYellow stress signals, 2/10 points): Change of auditor (8-K Item 4.01).
Where can I read the latest news about CorMedix Inc.?
Recent headlines about CorMedix Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does CorMedix Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of CorMedix Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.